Last reviewed · How we verify
Placebo for Ivermectin cream 1%
This is a placebo, meaning it has no active therapeutic effect.
This is a placebo, meaning it has no active therapeutic effect. Used for Treatment of rosacea.
At a glance
| Generic name | Placebo for Ivermectin cream 1% |
|---|---|
| Sponsor | Zydus Worldwide DMCC |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not interact with any biological systems or molecular targets. It is used as a control in clinical trials to compare the efficacy of active treatments.
Approved indications
- Treatment of rosacea
Common side effects
- Local skin reactions
Key clinical trials
- Ivermectin/ Permethrin for Scabies (PHASE4)
- Oracea Soolantra Association in Participants With Severe Rosacea (PHASE4)
- MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea. (PHASE4)
- Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea (PHASE3)
- Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo for Ivermectin cream 1% CI brief — competitive landscape report
- Placebo for Ivermectin cream 1% updates RSS · CI watch RSS
- Zydus Worldwide DMCC portfolio CI